Paragon 28®, Inc. Acquires the Assets of Additive Orthopaedics

Paragon 28®, Inc. Acquires the Assets of Additive Orthopaedics

06.01.21

DENVERJune 1, 2021 /PRNewswire/ — Paragon 28, Inc., a market-leading orthopedic medical device company focused exclusively on the foot-and-ankle, today announced that the Company has acquired the product lines of Additive Orthopaedics (“Additive”).

The Additive 3D-printed Patient Specific Talus Spacer was approved on February 17, 2021 by the US Food and Drug Administration (“FDA”) and is the first and only patient-specific total talus replacement implant authorized for use in the United States.

Read the full article here.